Skip to content

Combating Rising Tuberculosis in New York

Page • 2018As unbelievable as it sounds in 2018, despite being preventable and curable Tuberculosis (TB) is on the rise in New York City for the first time in 25 years. Cases of drug-resistant TB, which are much more difficult and costly to treat, are increasing as well. This resurgence of TB is a direct result of…

Activists Urge National TB Programs and Treatment Providers To Discontinue Use of Harmful Injectable Agents in TB Treatment

Statement / Press • 2018
Activists from around the world called on National TB Programs to discontinue routine use of harmful injectable agents in treatment regimens for drug-resistant tuberculosis, in favor of newer, safer World Health Organization (WHO)-recommended treatments.

Activists Call on Countries and Donors to Immediately Scale Up Use of Life-Saving TB LAM Test

Statement / Press • 2018
At the TB 2018 pre-conference held on Sunday 22 July 2018, before the International AIDS Conference in Amsterdam, activists from around the globe called on their countries, development partners, and donors, to end the unacceptable death rates caused by TB in people living with HIV by immediately scaling up the use of TB LAM testing.

The United Nations’ Back Yard: TB Elimination in New York State and the U.S.

TAGline • 2018
By Erica Lessem The road from Moscow has led us back to New York, home of the United Nations (UN) and TAG headquarters. New York is also home to one of the largest tuberculosis (TB) burdens in the U.S.[1] Incidence in New York City rose in 2017, and multidrug-resistant TB (MDR-TB), which is costly and…

The Role of Vaccines and Cures in HIV Elimination

TAGline • 2018
By Richard Jefferys The development of highly effective approaches to HIV treatment and prevention—in the form of combination antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP)—stands among the most impressive scientific achievements in human history. As detailed elsewhere in this issue of TAGline, the widespread implementation of these interventions has the potential, at least theoretically, to…

New York Community Groups Call on City, State, Federal Actors to Increase Funding for Tuberculosis

Statement / Press • 2018
Advocates alarmed that budget cuts led to first rise in TB cases in New York City in over 25 years.

It’s Time to Deliver – Including Pregnant and Lactating Women in Clinical Research

Webinars • 2018
Pregnant women have frequently been excluded from or de-prioritized in clinical research initiatives due to a multitude of factors, such as the complex physiology of pregnant women, the risk studies may pose to the fetus, and the classification of pregnant women as a vulnerable population, among others. This neglect has left pregnant women and their…

Research Toward a Cure and Immune-Based Therapies

Pipeline • 2017
July 2017 By Richard Jefferys INTRODUCTION The research effort to cure HIV infection has continued to expand over the past year. The National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. National Institutes of Health (NIH) announced the funding of six new Martin Delaney Collaboratorys (up from three funded previously), which are collaborative…

Preventive Technologies: Antiretroviral and Vaccine Development

Pipeline • 2017
July 2017 By Jeremiah Johnson and Richard Jefferys INTRODUCTION Recent advances in the research, development, and implementation of biomedical HIV prevention—primarily in the form of treatment as prevention (TasP) and tenofovir disoproxil fumarate (TDF)/ emtricitabine (FTC) as pre-exposure prophylaxis (PrEP)—already appear to be bearing fruit in addressing complex HIV epidemics. At this year’s Conference on…

Just the Facts: Trump and the Devaluation of Science

TAGline • 2017
Mobilizing to defend biomedical research investments and scientific integrity as essential for public health, safety, and well-being By Kenyon Farrow and Mike Frick One of the more memorable moments of resistance to the Trump administration’s and GOP-controlled Congress’ plan to repeal the Affordable Care Act (ACA) took place on February 9, 2017 in Murfreesboro, Tennessee,…
Back To Top